2023 - Drug Delivery — Evaluating Off-The-Shelf and Novel Drug Delivery Solutions

During this session, featured speaker Brandon Bogdalek, will interview two industry leading panelists. The panelists will discuss important factors to consider when evaluating off-the-shelf (OTS) drug delivery platforms vs. developing a novel solution. Key topics will include cost and pricing impacts, timeline to commercialization, as well as R&D, human factors and user needs considerations. Panelists will share their perspectives with respect to choosing OTS solutions or building a novel drug delivery platform.
Discover the factors to consider when evaluating off-the-shelf (OTS) vs. novel drug delivery solutions. Register now.